Valuation : TransMedics Group, Inc.

Market Cap 2.85B 2.45B 2.32B 2.11B 3.95B 272B 3.97B 27.59B 10.61B 138B 10.7B 10.46B 437B P/E 2026 *
59x
P/E 2027 * 37.4x
Enterprise Value 2.81B 2.42B 2.29B 2.08B 3.89B 268B 3.91B 27.2B 10.46B 136B 10.54B 10.31B 431B EV / Sales 2026 *
3.79x
EV / Sales 2027 * 3.09x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day-3.36%
1 week-8.67%
Current month-3.17%
1 month-8.03%
3 months+11.67%
6 months-36.28%
Current year-32.45%
1 week 79.23
Extreme 79.23
89.55
1 month 79.23
Extreme 79.23
95.18
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 01/08/1998
Director of Finance/CFO 55 02/12/2024
Chief Operating Officer 43 02/02/2023
Director TitleAgeSince
Director/Board Member 57 01/08/1998
Chairman 81 01/01/2011
Director/Board Member 78 01/02/2016
Date Insider Type Main position Quantity % Market Cap. Importance
17/08/26 Don

Chairman

-18,000 0.0528%
10/07/26 Free

Chief Financial Officer

43,399 0.1273%
10/07/26 Free

Chief Operating Officer

29,511 0.0866%
Change 5-day change 1-year change 3-year change Capi.($)
-3.36%-8.67%-29.75%+38.05% 2.85B
+1.10%-0.65%+24.10%+18.43% 225B
-0.19%-3.62%+2.55%-20.00% 141B
+2.41%+0.67%-19.02%+22.09% 130B
-0.28%-10.08%-58.81%-21.22% 62.29B
-2.77%-6.15%+8.15%+12.69% 48.63B
-0.49%-1.97%-20.35%-15.53% 49.39B
+2.66%-2.61%+15.94%+29.91% 41.42B
+1.67%-0.25%+35.01%+55.09% 40.12B
-0.60%-4.41%-20.52%+44.06% 31.23B
Average +0.02%-3.95%-6.27%+16.36% 77.25B
Weighted average by Cap. +0.51%-2.52%+0.49%+9.95%

Financials

2026 *2027 *
Net sales 742M 639M 605M 548M 1.03B 70.86B 1.03B 7.19B 2.76B 36.05B 2.79B 2.72B 114B 875M 754M 714M 647M 1.21B 83.57B 1.22B 8.48B 3.26B 42.52B 3.29B 3.21B 134B
Net income 51.99M 44.79M 42.41M 38.44M 72.12M 4.97B 72.49M 504M 194M 2.53B 195M 191M 7.98B 89.08M 76.75M 72.67M 65.87M 124M 8.51B 124M 863M 332M 4.33B 335M 327M 13.68B
Net Debt -40.26M -34.69M -32.84M -29.77M -55.85M -3.85B -56.13M -390M -150M -1.96B -151M -148M -6.18B -146M -125M -119M -108M -202M -13.91B -203M -1.41B -543M -7.08B -547M -535M -22.37B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
11/09/26 $82.18 -3.36% 1,247,318
10/09/26 $85.04 -1.57% 591,859
09/09/26 $86.40 -2.12% 665,155
08/09/26 $88.27 -1.90% 594,550
04/09/26 $89.98 +3.45% 542,804
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
82.18USD
Average target price
97.30USD
Spread / Average Target
+18.40%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!